Details for New Drug Application (NDA): 020762
✉ Email this page to a colleague
NDA 020762 describes NASONEX, which is a drug marketed by Organon Llc and Perrigo Pharma Intl and is included in two NDAs. Additional details are available on the NASONEX profile page.
The generic ingredient in NASONEX is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
The generic ingredient in NASONEX is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 020762
| Tradename: | NASONEX |
| Applicant: | Organon Llc |
| Ingredient: | mometasone furoate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020762
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Oct 1, 1997 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
